The coronary circulation in cyanotic congenital heart disease

International Journal of Cardiology

Volumn 97, Issue SUPPL. 1, 2004, Pages 79-86

  Perloff, Joseph K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coronary circulation; Cyanotic congenital heart disease

Indexed keywords

CHOLESTEROL; DIPYRIDAMOLE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGIOGRAPHY; ARTERIOGRAPHY; ARTERY DILATATION; CLINICAL TRIAL; CONFERENCE PAPER; CONGENITAL HEART DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CYANOSIS; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHOLESTEROL; COLLAGEN; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY VESSELS; EISENMENGER COMPLEX; FEMALE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; MUSCLE, SMOOTH; NITROGEN RADIOISOTOPES; PLATELET COUNT; POSITRON-EMISSION TOMOGRAPHY; REFERENCE VALUES; THROMBOCYTOPENIA;

EID: 10044269743     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.08.018     Document Type: Conference Paper

References (28)

1. L. Bjork Ectasia of the coronary arteries Radiology 87 1966 33 34
2. J.K. Perloff, C.W. Urchell, and W.C. Roberts Aneurysmal dilatation of the coronary arteries in cyanotic congenital heart disease Am. J. Med. 45 1968 802 810
3. J. Arias-Stella, and M. Topilsky Anatomy of the coronary circulation at high altitude High altitude physiology 1971 Churchill Livingstone Publishers Edinburgh 149 157
4. A. Kohler, D. Sun, and G. Kaley Role of shear stress and endothelial prostaglandins in flow and velocity-induced dilatation in vivo Circ. Res. 72 1993 1276 1284
5. O.A. Paniagua, M.B. Bryant, and J.A. Panza Role of endothelial nitric oxide in shear stress-induced vasodilatation of human microvasculature Circulation 103 2001 1752 1758
6. R. Chug, J.K. Perloff, M. Fishbein, et al. The prevalence and morphology of dilated extramural coronary arteries in adults with cyanotic congenital heart disease (in preparation).
7. K. Niwa, J.K. Perloff, and S. Bhuta Structural abnormalities of great arterial walls in congenital heart disease Circulation 103 2001 393 400
8. R.C. Brunken, J.K. Perloff, J. Czernin, et al. Myocardial perfusion and perfusion reserve in adults with cyanotic congenital heart disease (in preparation).
9. A. Fyfe, J.K. Perloff, K. Niwa, et al. Anti-atherogenic changes in cholesterol and lipoproteins in adults with cyanotic congenital heart disease are genetically determined (in preparation).
10. M. Lill, J.K. Perloff, M. Frantzen, et al. The pathogenesis of low platelet counts and thrombocytopenia in adults with cyanotic congenital heart disease (in preparation).
11. W. Leung, M.L. Satdius, and E.L. Alderman Determinants of normal coronary artery dimensions in humans Circulation 84 1991 2294 2306
12. R.N. MacAlpin, A.S. Abbasi, and J.H. Grollman Human coronary artery size during life Radiology 103 1973 567 576
13. W.V. Vieweg, J.S. Alpert, and A.D. Hagan Calibre and distribution of normal coronary arterial anatomy Catheter. Cardiovasc. Diagn. 2 1976 269 280
14. W.B. Kannel, W.P. Castelli, and T. Gordon Serum cholesterol, lipoproteins, and risk of coronary heart disease. The Framingham Study Ann. Intern. Med. 74 1971 1
15. D. Kruger, V. Stierle, and G. Herman Exercise-induced myocardial ischemia in isolated coronary artery ectasias and aneurysms ("dilated coronary arteriopathy") J. Am. Coll. Cardiol. 34 1999 1461 1470
16. A.E. Becker, and J. van Mantgem The coronary arteries in Marfan's syndrome Am. J. Cardiol. 36 1975 315 321
17. J.W. Gu, and T.H. Adair Hypoxia-induced expression of VEGF is reversible myocardial vascular smooth muscle cells Am. J. Physiol. 273 1997 H628 H633
18. J.F. Arnal, A.T. Dinh-Xuan, and M. Pueyo Endothelial derived nitric oxide and vascular physiology and pathology Cellular Molecular Life Sciences 55 1999 1078 1087
19. S. de Mendoza, H. Nucete, and E. Ineichen Lipids and lipoproteins in subjects at 1,000 and 3,500 meter altitude Arch. Environ. Health 34 1979 308 311
20. C. Napoli Influence of maternal hypercholesterolemia during pregnancy on progression of early atherosclerotic lesions in childhood Lancet 354 1999 1234 1241
21. H.S. Gilbert, H. Ginsberg, and R. Fagerstrom Characterization of hypocholesterolemia in myeloproliferative disease Am. J. Med. 71 1981 595 602
22. D. Steinberg, S. Parasarathy, and T.E. Carew Beyond cholesterol: modification of low density lipoprotein that decreases its atherogenicity N. Eng. Med. 320 1989 915 924
23. S. Adimoolam, and J.P. Cooke Endothelium derived nitric oxide: an antiatherogenic molecule J.A. Panza R.O. Camnon Endothelium, NO, and Atherosclerosis 1999 Futura Publishing Armonk, NY 167 257
24. F.F. Gross, and P. Lane Physiologic reaction of nitric oxide and hemoglobin Proc. Natl. Acad. Sci. 96 1999 9967 9969
25. P.N. Madhavan, L.L. Wu, and D.C. Hunt Serum bilirubin distribution and its relationship to cardiovascular risks in children and young adults Atherosclerosis 131 1997 107 113
26. J.K. Perloff, M.H. Rosove, and K.E. Sietwema Cyanotic congenital heart disease: a multisystem systemic disorder J.K. Perloff J.S. Child Congenital Heart Disease in Adults 2nd edition 1998 WB Saunders Philadelphia 199 226
27. E.A. Trowbrigde, J.F. Martin, and D.N. Slater Evidence for a theory of physical fragmentation of megakaryocytes implying that all platelets are produced in the pulmonary circulation Thromb. Res. 28 1982 447 461
28. H. Horigome, Y. Hiramatsu, and O. Shigeta Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia J. Am. Coll. Cardiol. 39 2002 1072 1077